Acute ischemic colitis associated with oral decongestant use: a systematic review
Background and aim: Acute ischemic colitis (IC) has been linked with the use of oral decongestants. However, clinical evidence on this association remains limited. We aim to evaluate the occurrence and clinical outcomes of acute IC following over-the-counter (OTC) use of pseudoephedrine and phenylephrine.
Methods: We conducted a systematic review of the MEDLINE, Google Scholar, Scopus, and Embase databases between inception and July 20, 2022. Specific search terms were used. The inclusion criteria consisted of English-language articles describing acute IC secondary to pseudoephedrine or phenylephrine.
Results: A total of 18 case reports (level of clinical evidence: IV) fulfilled our inclusion criteria. The mean age of patients was 51.6 ± 15.3 years, with 14 (77.8%) cases reported in women. Clinical presentation was mainly related to abdominal pain 16 (88.9%), hematochezia 15 (83.3%), and/or abdominal tenderness 10 (55.6%). The medical background showed that 5 (27.8%) patients were previously healthy. In the 13 (72.2%) patients with comorbidities, hypertension 6 (46.2%), a history of tobacco use 5 (38.5%), and psychiatric illnesses 4 (30.8%) were commonly reported. Leukocytosis was encountered in 13 (72.2%) patients. Diagnostic investigations included a combination of CT scan and colonoscopy in 10 (55.6%), colonoscopy alone in 6 (33.3%), and flexible sigmoidoscopy in 1 (5.6%) patient. Colonoscopic biopsy was the mainstay of diagnosis in 15 (83.3%) patients. Treatment was based on supportive care in 18 (100%), concurrent antibiotic use in 2 (11.1%), and surgical intervention in 1 (5.6%) patient. Recurrent episodes of IC occurred in 4 (22.2%) patients.
Conclusions: Acute IC secondary to oral decongestants remains a rare but important clinical phenomenon. Clinical suspicion and imaging findings are important for early diagnosis.
Relevance to patients: In unexplained cases of IC, clinicians should specifically inquire about oral decongestants since they are OTC and patients commonly fail to reveal their usage. These drugs should be avoided for transient cold symptoms, especially in women.
[1] Yadav S, Dave M, Varayil JE, Harmsen WS, Tremaine WJ, Zinsmeister AR, et al. A Population-based Study of Incidence, Risk Factors, Clinical Spectrum, and Outcomes of Ischemic Colitis. Clin Gastroenterol Hepatol 2015;13:731-8.
[2] Montoro MA, Brandt LJ, Santolaria S, Gomollon F, Puértolas BS, Vera J, et al. Clinical Patterns and Outcomes of Ischaemic Colitis: Results of the Working Group for the Study of Ischaemic Colitis in Spain (CIE Study). Scand J Gastroenterol 2011;46:236-46.
[3] Amini A, Nagalli S. Bowel ischemia. In: StatPearls. Treasure Island, FL: StatPearls Publishing; 2022. Available from: https://www.ncbi.nlm.nih.gov/books/NBK554527 [Last accessed on 2022 Jul 05].
[4] Ahmed M. Ischemic Bowel Disease in 2021. World J Gastroenterol 2021;27:4746-62.
[5] DynaMed. Decongestant Toxicity-Emergency Management. EBSCO Information Services. Available from: https:// www.dynamed.com/management/decongestant-toxicityemergency-management [Last accessed on 2022 Aug 01].
[6] United States of America. United States Code. Combat Methamphetamine Act of 2005, 21 U.S.C. § 830; 2011. Available from: https://www.deadiversion.usdoj.gov/meth/ cma2005.htm [Last accessed on 2022 Aug 01].
[7] Health Canada. Summary Safety review-over-the-counter Products Containing Pseudoephedrine-assessing the Potential Risk of Inflammation and Injury of the Large Intestine due to Insufficient Blood Supply (Ischemic Colitis). Ottawa, ON: Health Canada; 2016. Available from: https://www.canada.ca/ en/health-canada/services/drugs-health-products/medeffectcanada/safety-reviews/summary-safety-review-over-counterproducts-containing-pseudoephedrine-assessing-potentialrisk-inflammation-injury-large-intestine-insufficient-blood. html [Last accessed on 2022 Aug 01].
[8] Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta-analyses: The PRISMA Statement. PLoS Med 2009;6:e1000097.
[9] Schneider RP. Ischemic Colitis Caused by Decongestant? J Clin Gastroenterol 1995;21:335-6.
[10] Dowd J, Bailey D, Moussa K, Nair S, Doyle R, Culpepper-Morgan JA. Ischemic Colitis Associated with Pseudoephedrine: Four Cases. Am J Gastroenterol 1999;94:2430-4.
[11] Klestov A, Kubler P, Meulet J. Recurrent Ischaemic Colitis Associated with Pseudoephedrine Use. Intern Med J 2001;31:195-6.
[12] Lichtenstein GR, Yee NS. Ischemic Colitis Associated with Decongestant Use. Ann Intern Med 2000;132:682.
[13] Traino AA, Buckley NA, Bassett ML. Probable Ischemic Colitis Caused by Pseudoephedrine with Tramadol as a Possible Contributing Factor. Ann Pharmacother 2004;38:2068-70.
[14] Ward PW, Shaneyfelt TM, Roan RM. Acute Ischaemic Colitis Associated with Oral Phenylephrine Decongestant Use. BMJ Case Rep 2014;2014:bcr2013202518.
[15] Sherid M, Samo S, Husein H, Sulaiman S, Vainder JA. Pseudoephedrine-induced Ischemic Colitis: Case Report and Literature Review. J Dig Dis 2014;15:276-80.
[16] Lee JM, Sun SO, Jung JO, Yoo JW, Kim JY. Cases of Ischemic Colitis Associated with Pseudoephedrine. Korean J Intern Med 2014;2014:109.
[17] Ambesh P, Siddiqui S, Obiagwu C, Vincent D, Patel J, Somal N, et al. Pseudoephedrine Associated Ischemic Colitis. Am J Ther 2018;25:e604-6.
[18] Aziz M, Pervez A, Fatima R, Bansal A. Pseudoephedrine Induced Ischemic Colitis: A Case Report and Review of Literature. Case Rep Gastrointest Med 2018;2018:8761314.
[19] El-Alali E, Alhmoud T. Acute Ischemic Colitis due to Oral Phenylephrine. ACG Case Rep J 2020;7:e00459.
[20] Shehata A, Mallipudi RR, Khan Q, Itidiare M, Alquran L, Matin S, et al. Double Trouble: A Rare Case of Recurrent Ischemic Colitis Due to Pseudoephedrine. Am J Gastroenterol 2019:114;S898.
[21] Goraya MH, Awan JR, Saleem HM, Inayat F, Tarar ZI, Akhtar Z, et al. Acute Ischemic Colitis Secondary to Oral Phenylephrine: An Unusual Adverse Effect of a Common Drug. Am J Gastroenterol 2021;116:S777-8.
[22] Cappell MS. Colonic Toxicity of Administered Drugs and Chemicals. Am J Gastroenterol 2004;99:1175-90.
[23] Farooq U, Alcantar D, Ahmed Z, Abegunde AT. Outcomes of Vasoconstrictor-Induced Non-Occlusive Mesenteric Ischemia of Colon: A Systematic Review. Clin Med Res 2022;20:164-9.
[24] Wiener I, Tilkian AG, Palazzolo M. Coronary Artery Spasm and Myocardial Infarction in a Patient with Normal Coronary Arteries: Temporal Relationship to Pseudoephedrine Ingestion. Catheter Cardiovasc Diagn 1990;20:51-3.
[25] Hengstmann JH, Goronzy J. Pharmacokinetics of 3H-Phenylephrine in Man. Eur J Clin Pharmacol 1982;21:335-41.
[26] Kanfer I, Dowse R, Vuma V. Pharmacokinetics of Oral Decongestants. Pharmacotherapy 1993;13:116S-28.
[27] Atkinson HC, Stanescu I, Salem II, Potts AL, Anderson BJ. Increased Bioavailability of Phenylephrine by Co-administration of Acetaminophen: Results of Four Open-Label, Crossover Pharmacokinetic Trials in Healthy Volunteers. Eur J Clin Pharmacol 2015;71:151-8.
[28] Sherid M, Samo S, Sulaiman S, Husein H, Sethuraman SN, Thiruvaiyaru D, et al. Comparison of Ischemic Colitis in the Young and the Elderly. WMJ 2016;115:196-202.
[29] Yngvadottir Y, Karlsdottir BR, Hreinsson JP, Ragnarsson G, Mitev RU, Jonasson JG, et al. The incidence and Outcome of Ischemic Colitis in a Population-based Setting. Scand J Gastroenterol 2017;52:704-10.
[30] Reame NE, Kelche RP, Beitins IZ, Yu MY, Zawacki CM, Padmanabhan V. Age Effects of Follicle-stimulating Hormone and Pulsatile Luteinizing Hormone Secretion Across the Menstrual Cycle of Premenopausal Women. J Clin Endocrinol Metab 1996;81:1512-8.
[31] Santoro N, Brown JR, Adel T, Skurnick JH. Characterization of Reproductive Hormonal Dynamics in the Perimenopause. J Clin Endocrinol Metab 1996;81:1495-501.
[32] Gilligan DM, Quyyumi AA, Cannon RO 3rd. Effects of Physiological Levels of Estrogen on Coronary Vasomotor Function in Postmenopausal Women. Circulation 1994;89:2545-51.
[33] Hashimoto M, Akishita M, Eto M, Ishikawa M, Kozaki K, Toba K, et al. Modulation of Endothelium-dependent Flow-mediated Dilatation of the Brachial Artery by Sex and Menstrual Cycle. Circulation 1995;92:3431-5.
[34] Wessler S. Estrogen-associated Thromboembolism. Ann Epidemiol 1992;2:439-43.
[35] Mishell DR Jr. Oral Contraception: Past, Present, and Future Perspectives. Int J Fertil 1992;37:7-18.
[36] Gerstman BB, Piper JM, Tomita DK, Ferguson WJ, Stadel BV, Lundin FE. Oral Contraceptive Estrogen Dose and the Risk of Deep Venous Thromboembolic Disease. Am J Epidemiol 1991;133:32-7.
[37] Fernández JC, Calvo LN, Vázquez EG, García MJ, Pérez MT, Silva IM, et al. Risk Factors Associated with the Development of Ischemic Colitis. World J Gastroenterol 2010;16:4564-9.
[38] Longstreth GF, Yao JF. Epidemiology, Clinical Features, High-risk Factors, and Outcome of Acute Large Bowel Ischemia. Clin Gastroenterol Hepatol 2009;7:1075-80.
[39] Feuerstadt P, Brandt LJ. Colon Ischemia: Recent Insights and Advances. Curr Gastroenterol Rep 2010;12:383-90.
[40] Iacobellis F, Narese D, Berritto D, Brillantino A, Di Serafino M, Guerrini S, et al. Large Bowel Ischemia/ Infarction: How to Recognize it and Make Differential Diagnosis? A Review. Diagnostics (Basel) 2021;11:998.
[41] Saleem S, Ishtiaq R, Inayat F, Aziz M, Bleibel W. Gastrointestinal and Liver Manifestations in COVID-19 Population. Middle East J Dig Dis 2021;13:281-6.
[42] Rahman AU, Inayat F, Ali S, Zahid E, Charles R. The Role of Oral Vancomycin in Inducing Remission for Biologicexperienced Ulcerative Colitis with Concomitant Primary Sclerosing Cholangitis and Liver Transplantation. Clin J Gastroenterol 2021;14:159-64.
[43] Inayat F, Ullah W, Hussain Q, Abdullah HM. Dieulafoy’s Lesion of the Colon and Rectum: ACase Series and Literature Review. BMJ Case Rep 2017;2017:bcr2017220431.
[44] Xu Y, Xiong L, Li Y, Jiang X, Xiong Z. Diagnostic Methods and Drug Therapies in Patients with Ischemic Colitis. Int J Colorectal Dis 2021;36:47-56.
[45] Mehmood A, Abdullah HM, Inayat F, Ullah W. Wolf in the Sheep’s Clothing: Intestinal Angioedema Mimicking Infectious Colitis. BMJ Case Rep 2018;11:e226682.
[46] Elder K, Lashner BA, Al Solaiman F. Clinical Approach to Colonic Ischemia. Cleve Clin J Med 2009;76:401-9.
[47] Rizwan R, Feuerstadt P. Bad Blood: Ischemic Conditions of the Large Bowel. Curr Opin Gastroenterol 2022;38:72-9.
[48] Malik A, Inayat F, Goraya MH, Shahzad E, Zaman MA. Severe Acute Colonic Diverticular Bleeding: The Efficacy of Rapid Bowel Preparation with 1 L Polyethylene Glycol Ascorbate Solution and Direct Endoscopic Hemoclipping for Successful Hemostasis. J Investig Med High Impact Case Rep 2021;9:2324709621994383.
[49] Zou X, Cao J, Yao Y, Liu W, Chen L. Endoscopic Findings and Clinicopathologic Characteristics of Ischemic Colitis: A Report of 85 Cases. Dig Dis Sci 2009;54:2009-15.
[50] Inayat F, Hussain Q, Shafique K, Tasleem SH, Hurairah A. Cytomegalovirus Colitis in Immunocompetent Patients. Cureus 2016;8:e869.
[51] Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A Method for Estimating the Probability of Adverse Drug Reactions. Clin Pharmacol Ther 1981;30:239-45.
[52] Brandt LJ, Feuerstadt P, Longstreth GF, Boley SJ, American College of Gastroenterology. ACG Clinical Guideline: Epidemiology, Risk Factors, Patterns of Presentation, Diagnosis, and Management of Colon Ischemia (CI). Am J Gastroenterol 2015;110:18-44. Publisher’s note Whioce Publishing remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
[53] Cosme A, Montoro M, Santolaria S, Sanchez-PuertolasAB, Ponce M, Durán M, et al. Prognosis and Follow-up of 135 Patients with Ischemic Colitis Over a Five-year Period. World J Gastroenterol 2013;19:8042-6.
[54] Sherid M, Sifuentes H, Samo S, Sulaiman S, Husein H, Tupper R, et al. Risk Factors of Recurrent Ischemic Colitis: A Multicenter Retrospective Study. Korean J Gastroenterol 2014;63:283-91.